Syndax Pharmaceuticals, Inc. (SNDX), a Biotechnology business, was a gaining stock in the stock market session. Syndax Pharmaceuticals, Inc. (SNDX) shares opened at $18.35 and closed the day at $18.03 with positive move of +0.11%. This increase change lagged the S&P 500’s +1.69% gain on the stock market session.

Syndax Pharmaceuticals, Inc. (SNDX) is focused on the Biotechnology sector. This stock market sector has seen some action from traders in recent months. Bullish traders of Syndax Pharmaceuticals, Inc. (SNDX) will be looking for positive upcoming earnings whereas bearish traders of Syndax Pharmaceuticals, Inc. (SNDX) will be looking for negative earnings. The last time Syndax Pharmaceuticals, Inc. (SNDX) had an earnings surprise was on Qtr Ending 03/20 when they reported -$0.56 compared to an estimate of -$0.51 which was a difference of -$0.05 resulting in a change of -9.80%. Current earnings estimates are to be released for Current Qtr 06/2020 on Syndax Pharmaceuticals, Inc. (SNDX) and out of 3 Wall Street estimates the average is saying -$0.52. The high estimate is saying -$0.49 whereas the low estimate is saying -$0.57 and the prior year Syndax Pharmaceuticals, Inc. (SNDX) announced earnings at -$0.47 a growth rate est. (year over year) of -10.64%.

The market performance of Syndax Pharmaceuticals, Inc. (SNDX) has varied recently. Year to date Syndax Pharmaceuticals, Inc. (SNDX)’s shares are up 105.35%. Over the past 12 weeks Syndax Pharmaceuticals, Inc. (SNDX) is up 88.40% and over the last 4 weeks Syndax Pharmaceuticals, Inc. (SNDX) is up 77.81%. Syndax Pharmaceuticals, Inc. (SNDX) current income statement shows revenue (ttm) of $1.52M. Gross Profit is $1.52M. This puts the current EBITDA of Syndax Pharmaceuticals, Inc. (SNDX) at $-57.73M.

Wall street traders might also notice recent changes to stock analyst estimates for Syndax Pharmaceuticals, Inc. (SNDX). The stock is trading with an RSI (relative strength index) of 67.35 indicating Syndax Pharmaceuticals, Inc. (SNDX) is neither overbought nor oversold. Technically, SNDX’s short term support levels are around $1367.66, $1334.96 and $1286.57 on the downside. SNDXs short term resistance levels are $1526.69, $1493.59 and $1432.99 on the upside. The market cap of Syndax Pharmaceuticals, Inc. (SNDX) is $545.242M and institutions hold 56.57% of the stock. The outstanding share count stands at 35.69M while the short float (shares short) stands at 5.39%.

Research indicates that these financial estimate changes look to be directly correlated with short-term shares prices. The traders can look to capitalize on the basis of ranking. Based on technical analysis, SNDX has short term rating of Bullish (0.38), Intermediate rating of Bullish (0.35) and the long-term rating of Bullish (0.46) giving it an overall rating of Bullish (0.40).

The EPS growth this year on Syndax Pharmaceuticals, Inc. (SNDX) is increased 36.90% and is expected to increase 14.50% next year. However, quarterly earnings (EPS) growth year over year on Syndax Pharmaceuticals, Inc. (SNDX) has increased by 37.00% while return on equity (ttm) is -122.00%.

Recent Developments:

2020-05-07 – Syndax Pharmaceuticals Q1 Loss Per Share $0.56.
2020-04-29 – Syndax Announces Proposed Public Offering Of Common Stock.
2020-01-31 – Syndax Announces $35.0 Million Offering Of Common Stock.
2020-01-10 – Syndax Pharma Highlights 2020 Clinical and Corporate Outlook.
2019-11-07 – Syndax Pharmaceuticals Reports Q3 Loss Per Share Of $0.41.

About Company:

Syndax Pharmaceuticals, Inc. is a biopharmaceutical company which focused on the development and commercialization of entinostat, an epigenetic therapy for treatment-resistant cancers. The Company’s product pipeline includes ENCORE 601, ENCORE 602, J1353, NCI-7870, NCI-9844, E2112, NCI-8871 and NCI-9253 which are in clinical trial stage.

The Walt Disney Company (DIS), a Entertainment corporation, was a gaining stock in the prior market session. The Walt Disney Company (DIS) shares started the day for trading at $108.40 and closed the day at $107.77 with losses of -1.27%. The decrease change in The Walt Disney Company (DIS) lagged the change in the NASDAQ, a tech heavy index, for the day which lossed -0.45% in prior market session.

AT&T Inc. (T), a Telecom Services corporation, was a gaining stock in the previous trading session. AT&T Inc. (T) stock started the day for trading at $30.85 and closed the day at $31.23 with momentum of +3.55%. The increase movement in AT&T Inc. (T) beat the movement in the DOW for the day which gained +2.99% in previous trading session.

AT&T Inc. (T) is focused on the Telecom Services sector. This sector has seen some action from day traders in recent days. Bullish day traders of AT&T Inc. (T) will be looking for positive upcoming earnings whereas bearish day traders of AT&T Inc. (T) will be looking for negative earnings. The last time AT&T Inc. (T) had an earnings surprise was on Qtr Ending 12/19 when they reported $0.89 compared to an estimate of $0.88 which was a difference of $+0.01 resulting in a change of +1.14%. Current earnings estimates are to be released for Current Qtr 03/2020 on AT&T Inc. (T) and out of 18 Wall Street estimates the average is saying $0.85. The high estimate is saying $0.90 whereas the low estimate is saying $0.72 and the prior year AT&T Inc. (T) announced earnings at $0.86 a growth rate est. (year over year) of -1.16%.

The market performance of AT&T Inc. (T) has varied recently. Year to date AT&T Inc. (T)’s shares are down -20.09%. Over the past 12 weeks AT&T Inc. (T) is down -19.16% and over the last 4 weeks AT&T Inc. (T) is up 0.26%. AT&T Inc. (T) current income statement shows revenue (ttm) of $181.19B. Gross Profit is $97.05B. This puts the current EBITDA of AT&T Inc. (T) at $52.64B.

Wall street day traders might also notice recent changes to stock analyst estimates for AT&T Inc. (T). The stock is trading with an RSI (relative strength index) of 50.14 indicating AT&T Inc. (T) is neither overbought nor oversold. Technically, T’s short term support levels are around $12.14, $174.19 and $165.30 on the downside. Ts short term resistance levels are $23.72, $23.12 and $22.49 on the upside. The market cap of AT&T Inc. (T) is $224.329B and institutions hold 57.52% of the stock. The outstanding share count stands at 7.31B while the short float (shares short) stands at 1.79%.

Research shows that these earning estimate changes look to be directly correlated with short-term stock prices. The day traders can look to capitalize on the basis of ranking. AT&T Inc. (T) has short term rating of Neutral (0.02), Intermediate rating of Neutral (-0.10) and long-term rating of Very Bearish (-0.54) giving AT&T Inc. (T) an overall rating of Neutral (-0.21).

The EPS growth this year on AT&T Inc. (T) is decreased -30.90% and is expected to increase 5.47% next year. However, quarterly earnings (EPS) growth year over year on AT&T Inc. (T) has decreased by -42.30% and quarterly revenue (Sales) growth year over year stands at -2.40%. Gross margin is detected at 53.60% that represents the percent of total sales revenue that the company retains after direct cost of goods sold. Net profit margin (ttm) is 7.70% while return on equity (ttm) is 7.50%.

Recent Developments:

2020-04-15 – WarnerMedia And Charter Communications Announce Distribution Agreement For HBO Max.
2020-04-07 – CNN Says Acquired Assets, Hired Development Team Of Canopy – Blog.
2020-04-07 – At&T Inc On April 6, Entered Into A $5.5 Billion Term Loan Credit Agreement.
2020-04-01 – Jason Kilar Named CEO Of Warnermedia.
2020-03-27 – At&T Sets Quarterly Dividend Of $0.52 Per Share.

About Company:

Based in Dallas, TX, AT&T Inc. is the second largest wireless service provider in North America and one of the world’s leading communications service carriers. Through its subsidiaries and affiliates, the company offers a wide range of communication and business solutions that include wireless, local exchange, long-distance, data/broadband and Internet, video, managed networking, wholesale and cloud-based services.